Company intelligence / Profile preview

Biomedica Foscama S.p.A.

Anagni, Lazio, Italy

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

The company operates as a vertically integrated pharmaceutical manufacturer with EU GMP certification. It supplies branded products to over 15 countries. Its lead clinical program, TAD®, is currently in Phase III trials evaluating efficacy and safety for preventing myocardial injury in hospitalized pneumonia patients. The company has modernized facilities capable of producing APIs, sterile injectables, lyophilized drugs, vaccines—including mRNA-based—and high containment products. No published results from the ongoing Phase III trial as of January 2025.

Therapeutic areas: OtherCardiovascular
Modalities: Small molecules (sterile and lyophilized products)Injectable formulations (ampoules, vials)Vaccines (including mRNA technology capability)
Industry: Biotech

Drug pipeline

1 asset

NEOTAD

Unknown

Partnerships

Partnership with ACS Dobfar for bulk production/high performance robotic vial filling

Beyond the preview

Go deeper on Biomedica Foscama S.p.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedica Foscama S.p.A..

Explore the full profile